Allianz Asset Management Gmb H Arcturus Therapeutics Holdings Inc. Transaction History

Allianz Asset Management Gmb H

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$24.35 - $44.39 $4.39 Million - $8 Million	180,116 New	180,116 $4.39 Million
Q2 2021 Aug 16, 2021	SELL	$25.79 - $42.11 $271,001 - $442,491	-10,508 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$38.75 - $86.92 $140,933 - $316,128	3,637 Added 52.93%	10,508 $434,000
Q4 2020 Feb 16, 2021	SELL	$34.61 - $123.66 $688,531 - $2.46 Million	-19,894 Reduced 74.33%	6,871 $298,000
Q3 2020 Nov 13, 2020	SELL	$37.49 - $63.19 $317,165 - $534,587	-8,460 Reduced 24.02%	26,765 $1.15 Million
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $445,948 - $2.05 Million	35,225 New	35,225 $1.65 Million

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $450M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.